Lexeo Therapeutics (LXEO) Financials

Balance sheets

Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 1, 2023Dec 31, 2022Sep 1, 2022Jun 30, 2022

Total Assets

$173.9 M(-9.4%)$192.0 M(-9.9%)$213.2 M(+52.5%)$139.8 M(+155.5%)$54.7 M(-15.7%)$64.9 M-$97.1 M--

Current Assets

$159.5 M(-10.0%)$177.1 M(-10.6%)$198.1 M(+59.4%)$124.3 M(+219.7%)$38.9 M(-20.2%)$48.7 M-$80.0 M--

Non Current Assets

$14.4 M(-3.0%)$14.9 M(-1.7%)$15.1 M(-2.6%)$15.5 M(-2.1%)$15.8 M(-2.3%)$16.2 M-$17.0 M--

Total Liabilities

$34.5 M(+27.6%)$27.1 M(-10.6%)$30.3 M(+15.2%)$26.3 M(-87.9%)$217.5 M(+4.3%)$208.6 M-$210.0 M--

Current Liabilities

$26.8 M(+42.1%)$18.9 M(-12.7%)$21.6 M(+25.5%)$17.2 M(-25.2%)$23.0 M(+68.6%)$13.7 M-$14.3 M--

Long Term Liabilities

$7.7 M(-5.6%)$8.2 M(-5.1%)$8.6 M(-4.5%)$9.0 M(-95.4%)$194.5 M(-0.2%)$194.9 M-$195.7 M--

Shareholders Equity

$139.3 M(-15.5%)$164.9 M(-9.8%)$182.9 M(+61.1%)$113.5 M(+169.7%)-$162.8 M(-13.4%)-$143.6 M--$113.0 M--

Book Value

$139.3 M(-15.5%)$164.9 M(-9.8%)$182.9 M(+61.1%)$113.5 M(+169.7%)-$162.8 M(-13.4%)-$143.6 M--$113.0 M--

Working Capital

$132.6 M(-16.2%)$158.3 M(-10.3%)$176.5 M(+64.8%)$107.1 M(+575.9%)$15.8 M(-54.8%)$35.1 M-$65.7 M--

Cash And Cash Equivalents

$157.0 M(-10.3%)$175.0 M(-10.3%)$195.1 M(+60.6%)$121.5 M(+242.7%)$35.4 M(-22.2%)$45.5 M-$77.3 M--

Accounts Payable

$8.4 M(+46.4%)$5.8 M(+34.2%)$4.3 M(+13.3%)$3.8 M(+42.9%)$2.7 M(+12.1%)$2.4 M-$2.7 M--

Accounts Receivable

----------

Short Term Debt

$2.7 M(+0.5%)$2.7 M(+2.3%)$2.6 M(+0.2%)$2.6 M(-61.4%)$6.7 M(+141.5%)$2.8 M-$2.8 M--

Long Term Debt

$7.7 M(-5.6%)$8.2 M(-5.1%)$8.6 M(-4.5%)$9.0 M(-4.5%)$9.5 M(-4.1%)$9.9 M-$10.6 M--

Total Debt

$10.4 M(-4.1%)$10.9 M(-3.4%)$11.2 M(-3.5%)$11.6 M(-28.2%)$16.2 M(+28.1%)$12.7 M(+100.0%)$0.0(-100.0%)$13.5 M(+100.0%)$0.0(0%)$0.0

Debt To Equity

0.1(0%)0.1(+16.7%)0.1(-40.0%)0.1(+200.0%)-0.1(-11.1%)-0.1--0.1--

Current Ratio

6.0(-36.6%)9.4(+2.4%)9.2(+27.1%)7.2(+326.6%)1.7(-52.7%)3.6-5.6--

Quick Ratio

----------

Inventory

----------

Retained Earnings

-$254.2 M(-13.1%)-$224.8 M(-10.4%)-$203.5 M(-11.9%)-$181.8 M(-8.5%)-$167.7 M(-13.6%)-$147.5 M--$115.4 M--

PB Ratio

2.1(-33.3%)3.2(+13.8%)2.8(-10.5%)3.1------

Income statements

Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 1, 2023Dec 31, 2022Sep 1, 2022Jun 30, 2022

EPS

-$0.9(-39.1%)-$0.6(+16.9%)-$0.8(-44.6%)-$0.5(+33.4%)-$0.8(-49.6%)-$0.5(+28.0%)-$0.7(-28.0%)-$0.6(+14.5%)-$0.7(-12.6%)-$0.6

TTM EPS

-$2.8(-3.3%)-$2.7(-4.0%)-$2.6(-1.1%)-$2.6(+1.8%)-$2.7(-4.8%)-$2.5(+2.6%)-$2.6(-39.9%)-$1.9(-45.3%)-$1.3(-112.6%)-$0.6

Revenue

--------$531.0 K(+1335.1%)$37.0 K

TTM Revenue

--------$568.0 K(+1435.1%)$37.0 K

Total Expenses

$31.5 M(+33.9%)$23.6 M(+1.1%)$23.3 M(+55.5%)$15.0 M(-26.1%)$20.3 M(+45.1%)$14.0 M(-27.6%)$19.3 M(+26.9%)$15.2 M(-15.6%)$18.0 M(+17.4%)$15.3 M

Operating Expenses

$31.5 M(+33.9%)$23.6 M(+1.1%)$23.3 M(+55.5%)$15.0 M(-26.1%)$20.3 M(+45.1%)$14.0 M(-27.6%)$19.3 M(+26.9%)$15.2 M(-15.6%)$18.0 M(+17.4%)$15.3 M

Cost Of Goods Sold

----------

TTM Cost Of Goods Sold

----------

Gross Profit

----------

TTM Gross Profit

----------

Gross Margin

----------

Operating Profit

-$31.5 M(-33.9%)-$23.6 M(-1.1%)-$23.3 M(-55.5%)-$15.0 M(+26.1%)-$20.3 M(-45.1%)-$14.0 M(+27.6%)-$19.3 M(-26.9%)-$15.2 M(+13.1%)-$17.5 M(-14.2%)-$15.3 M

TTM Operating Profit

-$93.4 M(-13.7%)-$82.1 M(-13.2%)-$72.5 M(-5.8%)-$68.5 M(+0.3%)-$68.7 M(-4.2%)-$65.9 M(+2.0%)-$67.3 M(-40.2%)-$48.0 M(-46.3%)-$32.8 M(-114.2%)-$15.3 M

Operating Margin

---------3292.3%(+92.0%)-41.4 K%

Net Income

-$29.5 M(-38.9%)-$21.2 M(+2.0%)-$21.7 M(-52.8%)-$14.2 M(+29.4%)-$20.1 M(-49.6%)-$13.4 M(+28.0%)-$18.7 M(-28.0%)-$14.6 M(+14.5%)-$17.1 M(-12.6%)-$15.1 M

TTM Net Income

-$86.6 M(-12.2%)-$77.2 M(-11.2%)-$69.4 M(-4.6%)-$66.4 M(+0.6%)-$66.8 M(-4.8%)-$63.7 M(+2.6%)-$65.4 M(-39.9%)-$46.8 M(-45.3%)-$32.2 M(-112.6%)-$15.1 M

Net Margin

---------3211.9%(+92.2%)-40.9 K%

EBIT

-$29.5 M(-38.9%)-$21.2 M(+2.0%)-$21.6 M(-53.1%)-$14.1 M(+29.5%)-$20.1 M(-49.8%)-$13.4 M(+28.1%)-$18.6 M(-28.1%)-$14.5 M(+14.7%)-$17.0 M(-12.5%)-$15.1 M

TTM EBIT

-$86.4 M(-12.2%)-$77.0 M(-11.3%)-$69.2 M(-4.6%)-$66.2 M(+0.6%)-$66.6 M(-4.8%)-$63.5 M(+2.7%)-$65.3 M(-39.9%)-$46.7 M(-45.2%)-$32.2 M(-112.5%)-$15.1 M

EBITDA

-$28.9 M(-39.8%)-$20.7 M(+2.2%)-$21.2 M(-55.1%)-$13.6 M(+30.4%)-$19.6 M(-51.4%)-$12.9 M(+28.7%)-$18.2 M(-29.0%)-$14.1 M(+15.6%)-$16.7 M(-10.2%)-$15.1 M

TTM EBITDA

-$84.5 M(-12.4%)-$75.1 M(-11.5%)-$67.4 M(-4.7%)-$64.3 M(+0.7%)-$64.8 M(-4.7%)-$61.9 M(+3.4%)-$64.1 M(-39.6%)-$45.9 M(-44.3%)-$31.8 M(-110.2%)-$15.1 M

Selling, General & Administrative Expenses

$8.1 M(+16.2%)$7.0 M(-7.4%)$7.5 M(+11.6%)$6.8 M(+123.5%)$3.0 M(+10.5%)$2.7 M(-4.0%)$2.9 M(-25.1%)$3.8 M(+43.7%)$2.7 M(-14.0%)$3.1 M

TTM SGA

$29.4 M(+20.9%)$24.3 M(+21.2%)$20.1 M(+30.5%)$15.4 M(+23.8%)$12.4 M(+3.1%)$12.1 M(-2.8%)$12.4 M(+29.9%)$9.5 M(+66.5%)$5.7 M(+86.0%)$3.1 M

Depreciation And Amortization

$509.0 K(+2.6%)$496.0 K(+4.2%)$476.0 K(-2.9%)$490.0 K(+6.5%)$460.0 K(+3.1%)$446.0 K(-0.2%)$447.0 K-$700.0 K(+95.5%)$358.0 K

TTM D&A

$2.0 M(+2.5%)$1.9 M(+2.7%)$1.9 M(+1.6%)$1.8 M(+36.2%)$1.4 M(-15.1%)$1.6 M(+5.8%)$1.5 M-$1.1 M(+195.5%)$358.0 K

Interest Expense

$35.0 K(0%)$35.0 K(-5.4%)$37.0 K(-26.0%)$50.0 K(-3.9%)$52.0 K(-1.9%)$53.0 K(+6.0%)$50.0 K(-7.4%)$54.0 K(+86.2%)$29.0 K(+222.2%)$9000.0

TTM Interest Expense

$157.0 K(-9.8%)$174.0 K(-9.4%)$192.0 K(-6.3%)$205.0 K(-1.9%)$209.0 K(+12.4%)$186.0 K(+31.0%)$142.0 K(+54.4%)$92.0 K(+142.1%)$38.0 K(+322.2%)$9000.0

Income Tax

$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0

TTM Income Tax

$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0

PE Ratio

----------

PS Ratio

----------

Cashflow statements

Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 1, 2023Dec 31, 2022Sep 1, 2022Jun 30, 2022

Cash From Operations

-$17.8 M(+11.6%)-$20.2 M(-35.5%)-$14.9 M(-6.3%)-$14.0 M(-0.2%)-$13.9 M(-5.7%)-$13.2 M(+28.2%)-$18.4 M--$37.9 M(-45.1%)-$26.1 M

TTM CFO

-$66.8 M(-6.1%)-$62.9 M(-12.4%)-$56.0 M(+5.9%)-$59.5 M(-30.7%)-$45.5 M(+34.5%)-$69.5 M(+15.7%)-$82.5 M--$64.1 M(-145.1%)-$26.1 M

Cash From Investing

-$83.0 K(+61.9%)-$218.0 K(-12.9%)-$193.0 K(-164.4%)-$73.0 K(-37.7%)-$53.0 K(-35.9%)-$39.0 K(-100.0%)$0.0--$794.0 K(-101.5%)-$394.0 K

TTM CFI

-$567.0 K(-5.6%)-$537.0 K(-50.0%)-$358.0 K(-117.0%)-$165.0 K(-79.3%)-$92.0 K(+89.0%)-$833.0 K(+29.9%)-$1.2 M--$1.2 M(-201.5%)-$394.0 K

Cash From Financing

-$72.0 K(-124.7%)$291.0 K(-99.7%)$88.7 M(-11.4%)$100.1 M(+2458.1%)$3.9 M(+4261.7%)-$94.0 K(+4.1%)-$98.0 K-$270.0 K(-11.5%)$305.0 K

TTM CFF

$188.9 M(-2.1%)$192.9 M(+0.2%)$192.5 M(+85.5%)$103.8 M(+2690.1%)$3.7 M(+4669.2%)$78.0 K(-83.7%)$477.0 K-$575.0 K(+88.5%)$305.0 K

Free Cash Flow

-$17.9 M(+12.2%)-$20.4 M(-35.3%)-$15.1 M(-7.2%)-$14.1 M(-0.4%)-$14.0 M(-5.8%)-$13.2 M(+28.0%)-$18.4 M--$38.7 M(-45.9%)-$26.5 M

TTM FCF

-$67.4 M(-6.1%)-$63.5 M(-12.7%)-$56.3 M(+5.5%)-$59.7 M(-30.8%)-$45.6 M(+35.2%)-$70.3 M(+15.9%)-$83.6 M--$65.3 M(-145.9%)-$26.5 M

CAPEX

--------$794.0 K(+101.5%)$394.0 K

TTM CAPEX

--------$1.2 M(+201.5%)$394.0 K

Dividends Paid

----------

TTM Dividends Paid

----------

TTM Dividend Per Share

----------

TTM Dividend Yield

----------

Payout Ratio

----------